Tin tức & Cập nhật

Chỉ hiển thị Multimedia
Ixekizumab effective for difficult-to-treat psoriatic arthritis

Ixekizumab effective for difficult-to-treat psoriatic arthritis

08 Dec 2021 bởiAudrey Abella

The monoclonal antibody ixekizumab improved the signs and symptoms of psoriatic arthritis (PsA) in PsA patients with inadequate response to one or two tumour necrosis factor inhibitors (TNFis), suggests results from a post hoc subanalysis of the SPIRIT-P2 trial.

Ixekizumab effective for difficult-to-treat psoriatic arthritis

08 Dec 2021
Tonsillectomy may lower risk of psoriasis

Tonsillectomy may lower risk of psoriasis

27 Nov 2021

Patients who received tonsillectomy have a lower risk of psoriasis, reports a study, following adjustment for baseline characteristics, comorbidities, and medical confounders relative to a comparison group.

Tonsillectomy may lower risk of psoriasis

27 Nov 2021
Patients with vitiligo at risk of hearing loss

Patients with vitiligo at risk of hearing loss

27 Nov 2021

A significant association exists between vitiligo and sensorineural hearing loss (SNHL), according to a recent study, which recommends audiologic assessment for early recognition and management of hearing loss in patients with vitiligo.

Patients with vitiligo at risk of hearing loss

27 Nov 2021
Hidradenitis suppurativa bidirectionally linked to atopic dermatitis

Hidradenitis suppurativa bidirectionally linked to atopic dermatitis

27 Nov 2021
Psoriasis ups risk of colorectal cancer

Psoriasis ups risk of colorectal cancer

26 Nov 2021

Patients with psoriasis appear to be at greater risk for developing colorectal cancer, suggests a recent study, noting how gastroenterology consultation and colonoscopic examination are indicated for such individuals presenting with bowel symptoms.

Psoriasis ups risk of colorectal cancer

26 Nov 2021